Areas of good practice
VTE risk assessment completed where required.
96.7%
VTE risk documented clearly.
96.7%
Priority gaps
VTE and bleeding risk reassessed at consultant review, clinical change or other locally required trigger. (target ≥ 90%)
51.7%
VTE risk assessment completed within 24 hours of admission. (target ≥ 95%)
73.3%
Contraindication to pharmacological prophylaxis documented where prophylaxis was not prescribed. (target ≥ 95%)
84.6%
Pharmacological prophylaxis decision documented. (target ≥ 95%)
91.7%
User commentary
Editable interpretation for reports and governance meetings.
Governance & safety implications
Any immediate VTE, bleeding, anticoagulation, renal dosing or prescribing safety concern identified during this audit must be escalated through local clinical, pharmacy and governance pathways. This tool does not replace local escalation processes.